ADIM
PTEN icon

Alpha DNA Investment Management’s Patterson-UTI PTEN Stock Holding History

Alpha DNA Investment Management’s Portfolio PTEN Stock Details PTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-64,368
Closed -$1.08M – 194
2022
Q4 		$1.08M Buy
64,368
+15,407
+31% +$254K 0.38% 83
2022
Q3 		$571K Buy
+48,961
New +$700K 0.47% 91
2022
Q2 		– Sell
-81,032
Closed -$1.25M – 160
2022
Q1 		$1.25M Buy
+81,032
New +$1.02M 0.88% 39

Other funds holding PTEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's PTEN Position: Q1 2023 in Review

Alpha DNA Investment Management sold out of Patterson-UTI (PTEN) in Q1 2023, closing a stake of 64,368 shares — an estimated $1.08M sold.

Alpha DNA Investment Management first reported a position in PTEN in Q1 2022 and held it in 3 quarters. The position peaked at $1.25M in Q1 2022. 285 funds tracked by Wall St. Rank hold PTEN as of Q1 2023.

  • Alpha DNA Investment Management reported no remaining Patterson-UTI position as of Q1 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 64,368 Patterson-UTI shares in Q1 2023, an estimated $1.08M.
  • Alpha DNA Investment Management first reported a position in Patterson-UTI in Q1 2022 and held it in 3 quarters.
  • Alpha DNA Investment Management's Patterson-UTI position peaked at $1.25M in Q1 2022.
  • 285 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2023.

Based on Alpha DNA Investment Management's 13F filing for Q1 2023, filed 5 May 2023.